Dermapharm Holding SE (DMP.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.12B |
| Enterprise Value | 2.97B |
| P/E Ratio | 13.56 |
| PEG Ratio | 0.35 |
| Price/Sales Ratio | 1.57 |
| Price/Book Ratio | 3.47 |
| Enterprise/Revenue | 2.4 |
| Enterprise/EBITDA | 8.39 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.22 |
Income Statement
| Revenue | 1.16B |
| Revenue/Share | 23.85 |
| Gross Profit | 391.71M |
| EBITDA | 314.31M |
| Net Income | 132.41M |
| Diluted EPS | 2.46 |
Balance Sheet
| Total Cash | 195.56M |
| Total Cash/Share | 3.95 |
| Total Debt | 1.17B |
| Total Debt/Equity | 2.18 |
| Current Ratio | 1.71 |
| Book Value Per Share | 10.76 |
Price History
| 52-Week Change | 14.66 |
| 52-Week High | 51.9 |
| 52-Week Low | 31.7 |
| Moving Average 50 Days | 41.32 |
| Moving Average 200 Days | 41.98 |
Statistics
| Average Volume | 31,552 |
| Shares Outstanding | 49.54M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.88 |
| Trailing Annual Dividend Yield | 2.34 |
| Payout Ratio | 0.33 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
